These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 12228309)

  • 21. NDV-3 protects mice from vulvovaginal candidiasis through T- and B-cell immune response.
    Ibrahim AS; Luo G; Gebremariam T; Lee H; Schmidt CS; Hennessey JP; French SW; Yeaman MR; Filler SG; Edwards JE
    Vaccine; 2013 Nov; 31(47):5549-56. PubMed ID: 24063977
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A highly immunogenic recombinant and truncated protein of the secreted aspartic proteases family (rSap2t) of Candida albicans as a mucosal anticandidal vaccine.
    Sandini S; La Valle R; Deaglio S; Malavasi F; Cassone A; De Bernardis F
    FEMS Immunol Med Microbiol; 2011 Jul; 62(2):215-24. PubMed ID: 21535228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunity to Candida.
    Fidel PL
    Oral Dis; 2002; 8 Suppl 2():69-75. PubMed ID: 12164664
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Candida albicans mannan extract-protein conjugates induce a protective immune response against experimental candidiasis.
    Han Y; Ulrich MA; Cutler JE
    J Infect Dis; 1999 Jun; 179(6):1477-84. PubMed ID: 10228070
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Circulating CD4 and CD8 T cells have little impact on host defense against experimental vaginal candidiasis.
    Fidel PL; Lynch ME; Sobel JD
    Infect Immun; 1995 Jul; 63(7):2403-8. PubMed ID: 7790050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunopathogenesis of recurrent vulvovaginal candidiasis.
    Fidel PL; Sobel JD
    Clin Microbiol Rev; 1996 Jul; 9(3):335-48. PubMed ID: 8809464
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased severity of Candida vaginitis in BALB/c nu/nu mice versus the parent strain is not abrogated by adoptive transfer of T cell enriched lymphocytes.
    Black CA; Eyers FM; Russell A; Dunkley ML; Clancy RL; Beagley KW
    J Reprod Immunol; 1999 Nov; 45(1):1-18. PubMed ID: 10660259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Local anticandidal immune responses in a rat model of vaginal infection by and protection against Candida albicans.
    de Bernardis F; Santoni G; Boccanera M; Spreghini E; Adriani D; Morelli L; Cassone A
    Infect Immun; 2000 Jun; 68(6):3297-304. PubMed ID: 10816477
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IgA and IgG antibodies to Candida albicans in the genital tract secretions of women with or without vaginal candidosis.
    Gough PM; Warnock DW; Richardson MD; Mansell NJ; King JM
    Sabouraudia; 1984; 22(4):265-71. PubMed ID: 6390734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local production of chemokines during experimental vaginal candidiasis.
    Saavedra M; Taylor B; Lukacs N; Fidel PL
    Infect Immun; 1999 Nov; 67(11):5820-6. PubMed ID: 10531235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.
    De Bernardis F; Boccanera M; Adriani D; Spreghini E; Santoni G; Cassone A
    Infect Immun; 1997 Aug; 65(8):3399-405. PubMed ID: 9234804
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An intravaginal live Candida challenge in humans leads to new hypotheses for the immunopathogenesis of vulvovaginal candidiasis.
    Fidel PL; Barousse M; Espinosa T; Ficarra M; Sturtevant J; Martin DH; Quayle AJ; Dunlap K
    Infect Immun; 2004 May; 72(5):2939-46. PubMed ID: 15102806
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epithelial cell-derived S100 calcium-binding proteins as key mediators in the hallmark acute neutrophil response during Candida vaginitis.
    Yano J; Lilly E; Barousse M; Fidel PL
    Infect Immun; 2010 Dec; 78(12):5126-37. PubMed ID: 20823201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liposomal Fba and Met6 peptide vaccination protects mice from disseminated candidiasis.
    Huang W-C; Eberle K; Colon JR; Lovell JF; Xin H
    mSphere; 2024 Jul; 9(7):e0018924. PubMed ID: 38904363
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Local humoral immunity in vulvovaginal candidiasis].
    Amouri I; Hadrich I; Abbes S; Sellami H; Ayadi A
    Ann Biol Clin (Paris); 2013; 71(2):151-5. PubMed ID: 23587578
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaginal eosinophils and IgE antibodies to Candida albicans in women with recurrent vaginitis.
    Witkin SS; Jeremias J; Ledger WJ
    J Med Vet Mycol; 1989; 27(1):57-8. PubMed ID: 2666634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.
    Bromuro C; Torosantucci A; Chiani P; Conti S; Polonelli L; Cassone A
    Infect Immun; 2002 Oct; 70(10):5462-70. PubMed ID: 12228271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. α-galactosylceramide-stimulated invariant natural killer T-cells play a protective role in murine vulvovaginal candidiasis by Candida albicans.
    Abe M; Kinjo Y; Sadamoto S; Shinozaki M; Nagi M; Shibuya K; Miyazaki Y
    PLoS One; 2021; 16(11):e0259306. PubMed ID: 34784362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Serum levels of antibodies for IgG, IgA, and IgM against the fungi antigen in psoriasis vulgaris].
    Liang YS; Wen HQ; Xiao R
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):638-40. PubMed ID: 15804080
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A vaccine and monoclonal antibodies that enhance mouse resistance to Candida albicans vaginal infection.
    Han Y; Morrison RP; Cutler JE
    Infect Immun; 1998 Dec; 66(12):5771-6. PubMed ID: 9826353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.